top of page
Search
Writer's pictureJohn Q Leonard

An Argument for the In-Licensing Biotech Business Model


Here is a concise article that was published recently in the BioEntrepreneur blog that makes a convincing argument in our opinion for pursuing an in-licensing business model approach to starting a pharmaceutical company. Note the figures, the inflection points in the valuation curve and the required investment to reach each milestone or potential exit point for investors.

https://www.nature.com/bioent/2003/030101/full/nbt0602supp-BE36.html


19 views0 comments
bottom of page